The Central European Institute of Technology (CEITEC) at Masaryk University was established in 2009 as an independent institute focused solely on research. Since 2011, it operates as part of the CEITEC consortium consisting of four leading Brno universities and two research institutes who joined forces in order to establish a supraregional centre of scientific excellence combining life sciences, advanced materials and nanotechnologies.
CEITEC provides access to 12 core facilities equipped with cutting-edge technologies in nanotechnologies and life material sciences. High-end instrumentation, funded through national and European projects, accessible to internal and external users from academy and industry at national and international levels. The majority of CEITEC core facilities are associated with Large Research Infrastructures for Research, Experimental Development and Innovations on the Roadmap of Czech Republic for the years 2016 – 2022.
Masaryk University (MU) is a public, non-profit educational and research organization, founded in 1919 as the second Czech university in Brno, the South Moravian Region. At present it comprises nine faculties and 2 university institutes with over 200 departments, institutes and clinics, more than 37 000 students and 4500 staff, making it the second largest university in the Czech Republic. The long-term aim of Masaryk University is to profile itself as a research university with an internationally respected research programme, distinct profile and research results visible in European context, a university actively involved in international collaboration both on European and global level.
CEITEC comprises 7 research programmes and 10 core facilities, with a total of 60 research groups, over 500 researchers and 25 000 m2 of new labs. The CEITEC project financed from the EU Structural Funds (worth 208 million EUR) ended in December 2015 and the research centre has shifted towards standard operation since.
One of the key and most productive programs of CEITEC institute is Molecular Medicine Program. Researchers there focus on the study of genetic background of human diseases (mainly cancer and immune disorders). Main objective of Molecular Medicine is to gain a better understanding of both the physiological processes and disease pathogenesis at the molecular level, introduce modern approaches of the genome analysis and characterize cell behavior on a molecular level, with emphasis on malignant transformation, and resistance to modern anti-cancer treatment. The collaboration with clinicians from nearby University Hospital Brno has proven extremely helpful and mutually beneficial in resolving key clinical and biomedical- relevant scientific questions.
Core Facility Genomics (CFG) offers genomic analysis service and access to up-to-date genomic instrumentation. Main technologies available at the facility are massively parallel sequencing (Illumina), single molecule nanopore sequencing, microarrays and high-throughput & digital PCR. Through cooperation with CEITEC Center of Molecular Medicine it is possible to access other instrumentation – cell sorter, flow cytometers or Laser Capture Microdissection.
THE CENTRAL EUROPEAN INSTITUTE OF TECHNOLOGY (CEITEC)
The European Commission's support for the production of this website does not constitute an endorsement of the contents, which reflect the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein